Tuis2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Vorige sluiting
$21,08
Dagwisseling
$21,00 - $21,36
Jaarwisseling
$12,44 - $29,00
Markkapitalisasie
74,53 mjd HKD
Gemiddelde volume
4,20 m
P/V-verhouding
15,86
Dividend-opbrengs
1,65%
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 9,88 mjd | -5,46% |
Bedryfskoste | 4,04 mjd | -3,24% |
Netto inkomste | 821,33 m | 4,52% |
Netto winsgrens | 8,31 | 10,51% |
Wins per aandeel | — | — |
EBITDA | 1,39 mjd | -9,66% |
Effektiewe belastingkoers | 14,57% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 13,51 mjd | -13,59% |
Totale bates | 118,12 mjd | 2,48% |
Totale aanspreeklikheid | 57,31 mjd | 2,21% |
Totale ekwiteit | 60,81 mjd | — |
Uitstaande aandele | 2,64 mjd | — |
Prys om te bespreek | 1,16 | — |
Opbrengs op bates | 1,60% | — |
Opbrengs op kapitaal | 1,95% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 821,33 m | 4,52% |
Kontant van bedrywe | 1,25 mjd | 15,57% |
Kontant van beleggings | -652,10 m | -410,17% |
Kontant van finansiering | -1,78 mjd | -12,01% |
Netto kontantverandering | -1,28 mjd | -228,19% |
Beskikbare kontantvloei | -3,64 mjd | -20,82% |
Meer oor
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Gestig
1994
Webwerf
Werknemers
40 234
